Alternate Approaches for Pediatric Type 1 Diabetes Drug Development and Potential Regulatory Approval: A Perspective

被引:4
作者
Turner, J. Rick [1 ]
Close, Kelly L. [2 ]
Fleming, G. Alexander [3 ]
Wherrett, Diane K. [4 ]
DiMeglio, Linda A. [5 ,6 ]
机构
[1] Quintiles, Diabet & Pediat Ctr Excellence, Durham, NC 27703 USA
[2] Close Concerns & diaTribe Fdn, San Francisco, CA USA
[3] Kinexum LLC, Harpers Ferry, WV USA
[4] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Endocrinol, Toronto, ON M5G 1X8, Canada
[5] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA
[6] Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN USA
关键词
EXCHANGE CLINIC REGISTRY; GLYCEMIC CONTROL; C-PEPTIDE; ADOLESCENTS; MELLITUS; CHILDREN; PREVALENCE; MEDICINES; DIAGNOSIS; DURATION;
D O I
10.2337/dc14-2707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence and prevalence of pediatric type 1 diabetes are increasing globally, including in the U.S. While the increasing number of cases of pediatric diabetes makes expeditious availability of new medical products and therapies for diabetes care essential, there have been many barriers encountered in bringing some drugs and devices to pediatric patients who may benefit. Newer insulins have been studied and approved for use in children. However, hurdles exist in the inclusion of children in studies of therapies aimed at preventing -cell loss in those with new-onset diabetes and those at risk for type 1 diabetes. This Perspective focuses on potential solutions to the challenges experienced in bringing new drugs for pediatric type 1 diabetes to marketing approval. Given their central importance as the users of medical products, patient perspectives are included along with scientific and regulatory considerations.
引用
收藏
页码:1986 / 1991
页数:6
相关论文
共 38 条
[11]   Continuing stability of center differences in pediatric diabetes care:: Do advances in diabetes treatment improve outcome?: The Hvidoere study group on childhood diabetes [J].
de Beaufort, Carine E. ;
Swift, Peter G. F. ;
Skinner, Chas T. ;
Aanstoot, Henk J. ;
Aman, Jan ;
Cameron, Fergus ;
Martul, Pedro ;
Chiarelli, Francesco ;
Daneman, Dennis ;
Danne, Thomas ;
Dorchy, Harry ;
Hoey, Hilary ;
Kaprio, Eero A. ;
Kaufman, Francine ;
Kocova, Mirjana ;
Mortensen, Henrik B. ;
Njolstad, Pal R. ;
Phillip, Moshe ;
Robertson, Kenneth J. ;
Schoenle, Eugen J. ;
Urakami, Tatsuhiko ;
Vanelli, Maurizio .
DIABETES CARE, 2007, 30 (09) :2245-2250
[12]   Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval [J].
Eichler, H-G ;
Oye, K. ;
Baird, L. G. ;
Abadie, E. ;
Brown, J. ;
Drum, C. L. ;
Ferguson, J. ;
Garner, S. ;
Honig, P. ;
Hukkelhoven, M. ;
Limn, J. C. W. ;
Lim, R. ;
Lumpkin, M. M. ;
Neil, G. ;
O'Rourke, B. ;
Pezalla, E. ;
Shoda, D. ;
Seyfert-Margolis, V. ;
Sigal, E. V. ;
Sobotka, J. ;
Tan, D. ;
Unger, T. F. ;
Hirsch, G. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (03) :426-437
[13]  
European Medicines Agency, 2013, WORKSH PAED INV PLAN
[14]   Regulatory and policy issues for T1DM immunotherapy [J].
Fleming, Alexander .
HUMAN VACCINES, 2011, 7 (01) :50-55
[15]  
Fleming G Alexander, 2009, J Diabetes Sci Technol, V3, P215
[16]  
Fleming GA, 2015, TRANSLATIONAL RES ME, P284
[17]   Fall in C-Peptide During First 2 Years From Diagnosis Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes Trial Net Data [J].
Greenbaum, Carla J. ;
Beam, Craig A. ;
Boulware, David ;
Gitelman, Stephen E. ;
Gottlieb, Peter A. ;
Herold, Kevan C. ;
Lachin, John M. ;
McGee, Paula ;
Palmer, Jerry P. ;
Pescovitz, Mark D. ;
Krause-Steinrauf, Heidi ;
Skyler, Jay S. ;
Sosenko, Jay M. .
DIABETES, 2012, 61 (08) :2066-2073
[18]  
Karges B, 2014, PLOS MED, V11
[19]   Joining Forces: A Call for Greater Collaboration to Study New Medicines in Children and Adolescents With Type 2 Diabetes [J].
Karres, Janina ;
Pratt, Valerie ;
Guettier, Jean-Marc ;
Temeck, Jean ;
Tamborlane, William V. ;
Dunger, David ;
Bejnariu, Cristina ;
De Beaufort, Carine ;
Tomasi, Paolo .
DIABETES CARE, 2014, 37 (10) :2665-2667
[20]  
Karres J, 2013, EXPERT REV CLIN PHAR, V6, P227, DOI [10.1586/ecp.13.9, 10.1586/ECP.13.9]